Abbott
Company profile
Primary focus
Healthcare technologies in diagnostics, medical devices, nutrition, and pharmaceuticals.
Why it’s included
The profile lists multiple rapid immunodiagnostic tests such as the 'Panbio™ COVID-19 Ag Rapid Test Device' and 'BinaxNOW COVID-19 Ag Card', and explicitly states the company develops and manufactures point-of-care molecular and antigen diagnostics, directly matching the topic's requirements.
Relevant capabilities
- Point-of-care and laboratory diagnostic test development (molecular, antigen, serology)
- Biomarker assay development and clinical/analytical validation
- Clinical laboratory automation and informatics integration
- Regulatory submissions and interactions with major health authorities
- Large-scale manufacturing and rapid production scale-up for diagnostics and devices
Commercial sectorInstrument-free rapid immunoassays
Technology classesConventional antibody-based lateral flow immunoassays
Relevant commercial products
- Panbio™ COVID-19 Ag Rapid Test Device
- Panbio COVID-19 Ag Rapid Test Device
- BinaxNOW COVID-19 Ag Card
- ID NOW™ COVID-19 24 Test Kit
Relevant patents
5 families, 5 publications- Magnetic immunosensor with trench configuration and method of use US-11402375-B2
- Combined immunoassay and magnetic immunoassay systems and devices for extended range of sensitivity US-11680944-B2
- Combined immunoassay and magnetic immunoassay methods for extended range of sensitivity US-12025614-B2
- Extended range immunoassay devices with immunosensor and magnetic immunosensor US-12601735-B2
- Devices and methods for sample analysis US-11369963-B2